Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of percutaneous coronary intervention alone in symptomatic patients with moderate and severe valvular aortic stenosis and coexisting coronary artery disease: analysis of results in 56 patients.
Kuchulakanti P, Rha SW, Satler LF, Suddath WO, Pichard AD, Kent KM, Weissman NJ, Cheneau E, Pakala R, Canos DA, Pinnow EE, Waksman R. Kuchulakanti P, et al. Among authors: pakala r. J Invasive Cardiol. 2004 Dec;16(12):688-91. J Invasive Cardiol. 2004. PMID: 15596870
Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis.
Kuchulakanti P, Rha SW, Satler LF, Suddath WO, Pichard AD, Kent KM, Pakala R, Canos DA, Pinnow EE, Waksman R. Kuchulakanti P, et al. Among authors: pakala r. Am J Cardiol. 2004 Jun 1;93(11):1394-7, A9. doi: 10.1016/j.amjcard.2004.02.038. Am J Cardiol. 2004. PMID: 15165922
Addition of heparin to contrast media is associated with increased bleeding and peripheral vascular complications during percutaneous coronary intervention with bivalirudin and drug-eluting stents.
Rha SW, Kuchulakanti PK, Pakala R, Cheneau E, Pinnow E, Gebreeyesus A, Aggrey G, Pichard AD, Satler LF, Kent KM, Lindsay J, Waksman R. Rha SW, et al. Among authors: pakala r. Cardiovasc Radiat Med. 2004 Apr-Jun;5(2):64-70. doi: 10.1016/j.carrad.2004.06.003. Cardiovasc Radiat Med. 2004. PMID: 15464942
Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device.
Rha SW, Kuchulakanti PK, Pakala R, Cheneau E, Pinnow E, Torguson R, Pichard AD, Satler LF, Suddath WO, Kent KM, Lindsay J, Waksman R. Rha SW, et al. Among authors: pakala r. Am J Cardiol. 2005 Jul 1;96(1):67-70. doi: 10.1016/j.amjcard.2005.02.047. Am J Cardiol. 2005. PMID: 15979436 Clinical Trial.
111 results